Acesso livre
Acesso livre

Arquivos do dia: Novembro 5, 2021

Estudo compara a queda da efetividade das vacinas da Moderna, da Pfizer e da Janssen, além das consequências para a mortalidade.

5 Nov, 2021 | 17:21h

Estudo original: SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 – Science

Comunicado de imprensa: Breakthrough Infection Study Compares Decline in Vaccine Effectiveness and Consequences for Mortality – Public Health Institute

 

Comentário no Twitter

 

Efeitos da pandemia de Covid-19 na expectativa de vida e na mortalidade prematura em 2020 – Esta análise mostrou que houve mais de 28 milhões de anos a mais de vida perdidos em 2020 em 31 países.

5 Nov, 2021 | 17:20h

Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries – The BMJ

Conteúdos relacionados:

Global Covid-19 deaths surpass five million.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Revisão | Transmissão do SARS-CoV-2 pelo ar em ambientes fechados é uma ameaça que pode ser combatida com ciência.

5 Nov, 2021 | 17:17h

SARS-CoV-2 indoor air transmission is a threat that can be addressed with science – Proceedings of the National Academies of Sciences

Conteúdos relacionados:

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

Editorial: Covid-19 has redefined airborne transmission

Covid-19: What do we know about airborne transmission of SARS-CoV-2?

Real-world data show that filters clean COVID-causing virus from air.

Perspective | The plan to stop every respiratory virus at once – “The benefits of ventilation reach far beyond the coronavirus. What if we stop taking colds and flus for granted, too?”

Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission.

We studied how to reduce airborne COVID spread in hospitals. Here’s what we learnt.

Report: Improved ventilation essential to safe use of buildings and public spaces, say leading engineers.

WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

Guidance: Using Ventilation and filtration to reduce aerosol transmission of COVID-19 in long-term care homes

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols.

 

Comentário no Twitter

 

Debate: os comprovantes de vacinação são uma alternativa válida ao lockdown?

5 Nov, 2021 | 17:15h

Are vaccine passports and covid passes a valid alternative to lockdown? – The BMJ

Comunicado de imprensa: Covid passes: the best way of preventing another lockdown or a threat to civil freedoms and rights? – BMJ

Reino Unido aprova a pílula antiviral da Merck para COVID-19.

5 Nov, 2021 | 17:14h

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first – NPR

Conteúdos relacionados:

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

Cuidados clínicos na estratificação de risco e tratamento de pacientes com doença hepática gordurosa não alcoólica.

5 Nov, 2021 | 17:12h

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Comunicado de imprensa: International experts develop Clinical Care Pathway in response to NASH epidemic – American Gastroenterology Association

Conteúdos relacionados:

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Estudo randomizado | Em pacientes com doença arterial coronariana de 3 vasos, uma estratégia de intervenção coronariana percutânea guiada por reserva de fluxo fracionada (fractional flow reserve – FFR) NÃO mostrou resultados comparáveis à cirurgia de revascularização do miocárdio – A incidência de 1 ano do desfecho primário composto (morte, infarto miocárdico ou AVC) foi de 7,3% no grupo de intervenção percutânea e de 5,2% no grupo cirúrgico.

5 Nov, 2021 | 17:11h

Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery – New England Journal of Medicine

Comentários:

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD – TCTMD

FAME 3: FFR-Guided PCI vs. CABG in Patients With Three-Vessel CAD – American College of Cardiology

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3 – FAME 3 – American College of Cardiology

 

Comentário no Twitter

 

Estudo randomizado por cluster | Em idosos com câncer avançado, um programa de avaliação geriátrica reduziu os efeitos tóxicos do tratamento.

5 Nov, 2021 | 17:09h

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study – The Lancet

Comunicado de imprensa: Less Chemotherapy, Personalized Care: Wilmot Study Reinforces Major Strides in Geriatric Oncology – University of Rochester Medical Center

Conteúdos relacionados:

RCT: A geriatric assessment–driven intervention can reduce chemotherapy-related toxic effects in older adults with cancer.

Perspective: A Cancer Care Approach Tailored to The Elderly May Have Better Results

 

Comentário da autora no Twitter (fio – clique para saber mais)

 

M-A | Denervação renal para hipertensão está associada com modesta redução no controle ambulatorial da pressão arterial (redução de 3,61 mmHg na pressão arterial sistólica e de 1,85 mmHg na pressão arterial diastólica).

5 Nov, 2021 | 17:07h

Renal Denervation for Hypertension: A Systematic Review and Meta-Analysis of Randomized, Blinded, Placebo-Controlled Trials – JACC: Cardiovascular Interventions

Comentários:

Meta-Analysis of Renal Denervation for Hypertension – American College of Cardiology

Is Renal Denervation a Useful Strategy in BP Management? – American College of Cardiology

Conteúdos relacionados:

#ACC21 – RCT: Among patients with resistant hypertension, ultrasound renal denervation resulted in a modest improvement in systolic BP (–4.5 mm Hg) vs. sham procedure.

Meta-Analysis: Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients with Hypertension

Coisas que fazemos sem nenhum motivo: prescrever tramadol para dor em pacientes internados.

5 Nov, 2021 | 17:05h

Conteúdos relacionados:

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.